Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation  - 102191

Spotlight
Video

Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation 

Cancer-News has 111 videos Subscribe Here

Loading........
Description: Andrew Chi, MD, PhD at NYU Langone Medical Center Explains Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Shared By : Cancer-News
Posted on : 03/20/18
Added : 5 months ago
Category : Brain Cancer



Recommended

Nothing found.